Company: FSTWF
Filing Date: 2025-05-15
Form Type: 20-F
Source: 0001213900-25-044386
Chunk: 62

Company: FST Corp.
Filing Date: 2025-05-15
Form: 20-F
Item: Item 4
Chunk 62
---
ing to the registration of
the Company’s FST trademarks in Taiwan (Registration Numbers 02307326, 02307516, and 02307578). This matter is still ongoing. The
Company is of the view that this matter would have minimal impact to its business, as the Company also has validly registered FST trademarks
in the U. S. and most of the Company’s sales are generated from the U. S. and countries other than Taiwan.

Trade Secrets

The Taiwan Trade Secret Act
mainly governs the following items: (1) the required elements of a trade secret; (2) ownership of a trade secret; (3) the
licensing of a trade secret; (4) misappropriation of a trade secret; (5) the civil remedy and criminal penalty for the misappropriation
of a trade secret; (6) the issuance of a protective order during criminal investigation. Pursuant to the Trade Secret Act, the information
that can be protected under the Trade Secret Act is defined as any method, technique, process, formula, program, design, or other information
that may be used in the course of production, sale or operation, and must meet the following requirements: (1) secrecy; (2) economic
value; and (3) reasonable measures to maintain secrecy. Under the Trade Secret Act, the types of misappropriation include acquisition,
use and divulging of a trade secret by unlawful means. The Trade Secret Act provides civil remedies and criminal penalties for trade-secret misappropriation.

The Company has never been
involved in trade secrets issues or disputes.

Regulations on Personal Data Protection

Under Taiwan law, the Personal
Data Protection Act is the main law governing personal data protection. Under the Personal Data Protection Act, unless otherwise specified,
a company is generally required to give notice to and obtain consent from an individual before collecting, processing, or using any of
the said individual’s personal information, subject to certain exceptions.

Pursuant to the Personal Data
Protection Act, the personal data pertaining to a natural person’s medical records, healthcare, genetics, sex life, physical examination
and criminal records is classified as sensitive personal data, which shall be subject to certain stricter obligations.

In addition to the Personal
Data Protection Act, when conducting the clinical trial, the sponsor and the investigator shall also comply with other relative regulations
or practices with regard to the protection of the subject’s personal data, such as the Human Subjects Research Act and the Regulations
on